Delayed recovery of effector memory CD4+ T cells by highly active antiretroviral therapy in a patient with HIV-1 infection

Shinji Okada, Miwako Kikuchi, Hitoshi Hasegawa, Masaaki Ishikawa, Isao Ohno, Mitsuo Kaku, Toshio Hattori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Effector memory T cells, which are potentially important in the protection against various pathogens, have been shown to be CCR7 negative. We report a case with HIV-1 infection in whom the change in the cell numbers of the subsets of CD4+ T cells, including CCR7 negative memory CD4+ T cells, in peripheral blood was monitored for more than one year after the initiation of highly active antiretroviral therapy. Percentage of each subsets in lymphocytes was measured by triple staining on lymphocyte fraction in flow-cytometry. The numbers of total CD4+ T cells, naive T cells, and CCR7 positive memory T cells successfully increased within half a month after the initiation of the therapy. Instead, the recovery of the cell number in CCR7 negative memory T cells delayed, and continued to increase until 10 months after the initiation of the therapy. It suggests the possibility of delay in recovery of immune systems after the initiation of the therapy in HIV-1-infected patients, despite the prompt recovery of total CD4+ T cells.

Original languageEnglish
Pages (from-to)213-218
Number of pages6
JournalTohoku Journal of Experimental Medicine
Volume196
Issue number3
DOIs
Publication statusPublished - 2002 Jan 1

Keywords

  • CCR7
  • Effector memory T cells
  • HAART
  • HIV-1 infection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Delayed recovery of effector memory CD4+ T cells by highly active antiretroviral therapy in a patient with HIV-1 infection'. Together they form a unique fingerprint.

  • Cite this